Short-term effects of bowel function on global health quality of life after radical cystectomy.


Journal

Minerva urology and nephrology
ISSN: 2724-6442
Titre abrégé: Minerva Urol Nephrol
Pays: Italy
ID NLM: 101777299

Informations de publication

Date de publication:
05 Jun 2024
Historique:
medline: 6 6 2024
pubmed: 6 6 2024
entrez: 6 6 2024
Statut: aheadofprint

Résumé

Radical cystectomy (RC) shows an important impact on quality of life (QoL), for various clinical aspects. The aim of our study was to evaluate the short-term bowel function in patients that underwent RC. Two hundred and six patients with MIBC underwent RC with ONB or IC urinary diversion. QoL was measured using the EORTC QLQ C30 and the Short-Form SF-36 questionnaires before surgery and at 12 months postoperatively. Baseline characteristics, including demographic profile, BMI, Charlson Comorbidity Index (CCI), modified Frailty Index (m-FI), pathological tumor stage, Clavien-Dindo grade, and neo-adjuvant chemotherapy were recorded and compared. The uni-variate and multivariate analysis (OR) were performed for constipation, diarrhea and m-FI of patients underwent RC for localized MIBC according to global health status score (poor/good vs very good). Multivariate analysis showed that constipation medium/high was significant associated with global health status poor/good (OR=2.39; 95% CI: 1.22-4.71; P=0.01); Diarrhea medium/high was associated with global health status poor/good (OR=2.85; 95% CI:1.18-6.92; P=0.02), and m-FI ≥2 score (OR=2.13; 95% CI: 0.99-4.57; P=0.05). Diarrhea and constipation are associated with a lower QoL in cystectomized patients, both with ONB or IC urinary diversion; such association is especially significant in more fragile patients (Frailty Index ≥2).

Sections du résumé

BACKGROUND BACKGROUND
Radical cystectomy (RC) shows an important impact on quality of life (QoL), for various clinical aspects. The aim of our study was to evaluate the short-term bowel function in patients that underwent RC.
METHODS METHODS
Two hundred and six patients with MIBC underwent RC with ONB or IC urinary diversion. QoL was measured using the EORTC QLQ C30 and the Short-Form SF-36 questionnaires before surgery and at 12 months postoperatively. Baseline characteristics, including demographic profile, BMI, Charlson Comorbidity Index (CCI), modified Frailty Index (m-FI), pathological tumor stage, Clavien-Dindo grade, and neo-adjuvant chemotherapy were recorded and compared.
RESULTS RESULTS
The uni-variate and multivariate analysis (OR) were performed for constipation, diarrhea and m-FI of patients underwent RC for localized MIBC according to global health status score (poor/good vs very good). Multivariate analysis showed that constipation medium/high was significant associated with global health status poor/good (OR=2.39; 95% CI: 1.22-4.71; P=0.01); Diarrhea medium/high was associated with global health status poor/good (OR=2.85; 95% CI:1.18-6.92; P=0.02), and m-FI ≥2 score (OR=2.13; 95% CI: 0.99-4.57; P=0.05).
CONCLUSIONS CONCLUSIONS
Diarrhea and constipation are associated with a lower QoL in cystectomized patients, both with ONB or IC urinary diversion; such association is especially significant in more fragile patients (Frailty Index ≥2).

Identifiants

pubmed: 38842052
pii: S2724-6051.24.05730-6
doi: 10.23736/S2724-6051.24.05730-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Salvatore Siracusano (S)

Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy - salvatore.siracusano@univaq.it.

Paolo Gontero (P)

Department of Urology, University of Turin, Turin, Italy.

Ettore Mearini (E)

Department of Urology, University of Perugia, Perugia, Italy.

Ciro Imbimbo (C)

Department of Urology, University Federico II, Naples, Italy.

Alchiede Simonato (A)

Department of Urology, University of Palermo, Palermo, Italy.

Fabrizio Dal Moro (F)

Department of Urology, University of Padua, Padua, Italy.

Gianluca Giannarini (G)

Department of Urology, Central Friuli University, Udine, Italy.

Francesco Montorsi (F)

Department of Urology, San Raffaele University, Milan, Italy.

Renzo Colombo (R)

Department of Urology, San Raffaele University, Milan, Italy.

Francesco Porpiglia (F)

Department of Urology, University Federico II, Naples, Italy.

Riccardo Bartoletti (R)

Department of Urology, University of Pisa, Pisa, Italy.

Andrea Minervini (A)

Department of Urology, University of Florence, Florence, Italy.

Marta Rossanese (M)

Department of Urology, University of Messina, Messina, Italy.

Antonio Porcaro (A)

Department of Urology, University of Verona, Verona, Italy.

Federico Romantini (F)

Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.

Igino A Magli (IA)

Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.

Savio D Pandolfo (SD)

Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.

Renato Talamini (R)

University of Verona, Verona, Italy.

Marco Racioppi (M)

Department of Urology, Catholic University, Rome, Italy.

Vincenzo Ficarra (V)

Department of Urology, University of Messina, Messina, Italy.

Cristina Lonardi (C)

Department of Human Sciences, University of Verona, Verona, Italy.

Classifications MeSH